Company filings profile · CIK 0001870404
CERO THERAPEUTICS HOLDINGS, INC. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for CERO THERAPEUTICS HOLDINGS, INC. (CERO): 8 filings in the last 90 days vs 16 in the prior 90 (filing-velocity cooling ↓ · 0.5×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 8, 2026. Source-linked, daily-refreshed.
Material 8-K events — CERO THERAPEUTICS HOLDINGS, INC.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Oct 7, 2026 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Aug 31, 2026 | Entry into a Material Agreement; Termination of a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jul 17, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jun 26, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| May 29, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| May 1, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Apr 14, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Mar 11, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Feb 13, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Change in Auditor; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Feb 4, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Feb 3, 2026 | Delisting / Listing-Rule Failure | ↗ |
Watch CERO THERAPEUTICS HOLDINGS, INC. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 7, 2026 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Aug 31, 2026 | 8-K | Entry into a Material Agreement; Termination of a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Aug 14, 2026 | 424B3 | PROSPECTUS SUPPLEMENT | ↗ |
| Aug 14, 2026 | 10-Q | QUARTERLY REPORT | ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 17, 2026 | 424B3 | PROSPECTUS SUPPLEMENT | ↗ |
| Jul 17, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jul 13, 2026 | 25-NSE | ↗ | |
| Jun 26, 2026 | 424B3 | PROSPECTUS SUPPLEMENT | ↗ |
| Jun 26, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| May 29, 2026 | 424B3 | PROSPECTUS SUPPLEMENT | ↗ |
| May 29, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| May 15, 2026 | 424B3 | PROSPECTUS SUPPLEMENT | ↗ |
| May 15, 2026 | 10-Q | QUARTERLY REPORT | ↗ |
| May 1, 2026 | 424B3 | PROSPECTUS SUPPLEMENT | ↗ |
| May 1, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| May 1, 2026 | 424B3 | PROSPECTUS SUPPLEMENT | ↗ |
| Apr 30, 2026 | 10-K/A | AMENDMENT NO. 1 TO FORM 10-K | ↗ |
| Apr 21, 2026 | 4 | ↗ | |
| Apr 21, 2026 | 3 | ↗ | |
| Apr 15, 2026 | 424B3 | PROSPECTUS SUPPLEMENT NO. 8 | ↗ |
| Apr 15, 2026 | 10-K | ANNUAL REPORT | ↗ |
| Apr 14, 2026 | 424B3 | PROSPECTUS SUPPLEMENT | ↗ |
| Apr 14, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Apr 1, 2026 | NT 10-K | NOTIFICATION OF LATE FILING | ↗ |
| Mar 12, 2026 | SCHEDULE 13G | ↗ | |
| Mar 11, 2026 | 424B3 | PROSPECTUS SUPPLEMENT | ↗ |
| Mar 11, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Feb 20, 2026 | 424B3 | PROSPECTUS SUPPLEMENT | ↗ |
| Feb 13, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Change in Auditor; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Feb 4, 2026 | 424B3 | PROSPECTUS SUPPLEMENT | ↗ |
| Feb 4, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Feb 3, 2026 | 424B3 | PROSPECTUS SUPPLEMENT | ↗ |
| Feb 3, 2026 | 8-K | Delisting / Listing-Rule Failure | ↗ |
| Jan 9, 2026 | 4 | ↗ | |
| Jan 9, 2026 | 4 | ↗ | |
| Jan 9, 2026 | 4 | ↗ | |
| Jan 9, 2026 | 4 | ↗ | |
| Jan 9, 2026 | 4 | ↗ | |
| Jan 9, 2026 | 4 | ↗ |